


The Fund aims to maximise long term total return.
| Name | % Net Assets | 
|---|---|
| Dunedin Smaller Companies | 4.7% | 
| British American Tobacco | 4.5% | 
| Royal Dutch Shell 'B' | 3.8% | 
| AstraZeneca | 3.6% | 
| HSBC | 3.6% | 
| Centrica | 3.5% | 
| Aviva | 3.1% | 
| Schroders | 3.1% | 
| Associated British Foods | 3.0% | 
| Tesco | 2.9% | 
| Key | % Net Assets | 
|---|---|
| 4.7% | |
| 4.5% | |
| 3.8% | |
| 3.6% | |
| 83.4% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | n/a | 
|---|---|
| Fund Manager | Pan European Equities Team | 
| TER | 2.13 (31-Jan-2009) | 
| Minimum Investment | |
|---|---|
| Initial | 500 | 
| Additional | 100 | 
| Savings | 50 | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.14 | 
You are here: research